author_facet van der Kouwe, Emiel
Staber, Philipp
van der Kouwe, Emiel
Staber, Philipp
author van der Kouwe, Emiel
Staber, Philipp
spellingShingle van der Kouwe, Emiel
Staber, Philipp
International Journal of Molecular Sciences
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
Inorganic Chemistry
Organic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Catalysis
author_sort van der kouwe, emiel
spelling van der Kouwe, Emiel Staber, Philipp 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms20020350 <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia International Journal of Molecular Sciences
doi_str_mv 10.3390/ijms20020350
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Physik
Informatik
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
imprint MDPI AG, 2019
imprint_str_mv MDPI AG, 2019
issn 1422-0067
issn_str_mv 1422-0067
language English
mega_collection MDPI AG (CrossRef)
match_str vanderkouwe2019runx1etoattackingtheepigenomeforgenomicinstableleukemia
publishDateSort 2019
publisher MDPI AG
recordtype ai
record_format ai
series International Journal of Molecular Sciences
source_id 49
title RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_unstemmed RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_full RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_fullStr RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_full_unstemmed RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_short RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_sort runx1-eto: attacking the epigenome for genomic instable leukemia
topic Inorganic Chemistry
Organic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Catalysis
url http://dx.doi.org/10.3390/ijms20020350
publishDate 2019
physical 350
description <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p>
container_issue 2
container_start_page 0
container_title International Journal of Molecular Sciences
container_volume 20
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792332133882134531
geogr_code not assigned
last_indexed 2024-03-01T13:52:01.025Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=RUNX1-ETO%3A+Attacking+the+Epigenome+for+Genomic+Instable+Leukemia&rft.date=2019-01-16&genre=article&issn=1422-0067&volume=20&issue=2&pages=350&jtitle=International+Journal+of+Molecular+Sciences&atitle=RUNX1-ETO%3A+Attacking+the+Epigenome+for+Genomic+Instable+Leukemia&aulast=Staber&aufirst=Philipp&rft_id=info%3Adoi%2F10.3390%2Fijms20020350&rft.language%5B0%5D=eng
SOLR
_version_ 1792332133882134531
author van der Kouwe, Emiel, Staber, Philipp
author_facet van der Kouwe, Emiel, Staber, Philipp, van der Kouwe, Emiel, Staber, Philipp
author_sort van der kouwe, emiel
container_issue 2
container_start_page 0
container_title International Journal of Molecular Sciences
container_volume 20
description <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p>
doi_str_mv 10.3390/ijms20020350
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Physik, Informatik, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjAwMjAzNTA
imprint MDPI AG, 2019
imprint_str_mv MDPI AG, 2019
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11
issn 1422-0067
issn_str_mv 1422-0067
language English
last_indexed 2024-03-01T13:52:01.025Z
match_str vanderkouwe2019runx1etoattackingtheepigenomeforgenomicinstableleukemia
mega_collection MDPI AG (CrossRef)
physical 350
publishDate 2019
publishDateSort 2019
publisher MDPI AG
record_format ai
recordtype ai
series International Journal of Molecular Sciences
source_id 49
spelling van der Kouwe, Emiel Staber, Philipp 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms20020350 <jats:p>Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the most common cytogenetic subtype of acute myeloid leukemia. RUNX1, a critical transcription factor in hematopoietic development, is fused with almost the entire ETO sequence with the ability to recruit a wide range of repressors. Past efforts in providing a comprehensive picture of the genome-wide localization and the target genes of RUNX1-ETO have been inconclusive in understanding the underlying mechanism by which it deregulates native RUNX1. In this review; we dissect the current data on the epigenetic impact of RUNX1 and RUNX1-ETO. Both share similarities however, in recent years, research focused on epigenetic factors to explain their differences. RUNX1-ETO impairs DNA repair mechanisms which compromises genomic stability and favors a mutator phenotype. Among an increasing pool of mutated factors, regulators of DNA methylation are frequently found in t(8;21) AML. Together with the alteration of both, histone markers and distal enhancer regulation, RUNX1-ETO might specifically disrupt normal chromatin structure. Epigenetic studies on the fusion protein uncovered new mechanisms contributing to leukemogenesis and hopefully will translate into clinical applications.</jats:p> RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia International Journal of Molecular Sciences
spellingShingle van der Kouwe, Emiel, Staber, Philipp, International Journal of Molecular Sciences, RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia, Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis
title RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_full RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_fullStr RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_full_unstemmed RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_short RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
title_sort runx1-eto: attacking the epigenome for genomic instable leukemia
title_unstemmed RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
topic Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis
url http://dx.doi.org/10.3390/ijms20020350